The Cancer Letter

Inside information on cancer research and drug development

In Brief

Maureen Testoni named 340B Health CEO

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Maureen Testoni has been named as the 340B Health CEO by the e 340B Health board of directors.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

The Trump administration “American Patients First” plan to reduce drug prices—
Are American cancer patients first?

In May 2018, President Trump announced his plan to lower drug prices. “We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter. And it will start to take effect very soon,” he promised. The plan is outlined in a 40-page document by the U.S. Department of Health and Human Services titled “American Patients First—The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Cost.” (1)
By Hagop M. Kantarjian and Mary Alma Welch
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account